1,938 Shares in HCA Healthcare, Inc. (NYSE:HCA) Bought by Drive Wealth Management LLC

Key Points

• Drive Wealth Management LLC has invested approximately $670,000 in HCA Healthcare, acquiring 1,938 shares during the first quarter of the year.
• HCA Healthcare reported earnings of $6.45 per share for the last quarter, exceeding analysts' expectations and reflecting a revenue increase of 5.7% year over year.
• Institutional investors currently hold 62.73% of HCA Healthcare's stock, indicating strong institutional interest and support for the company.

Drive Wealth Management LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,938 shares of the company's stock, valued at approximately $670,000.

A number of other hedge funds have also recently bought and sold shares of HCA. Sanders Capital LLC raised its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after buying an additional 116,826 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of HCA Healthcare by 1.3% in the 4th quarter. Geode Capital Management LLC now owns 3,871,057 shares of the company's stock valued at $1,159,882,000 after buying an additional 50,321 shares in the last quarter. Capital World Investors raised its stake in shares of HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after buying an additional 19,121 shares in the last quarter. Norges Bank acquired a new stake in shares of HCA Healthcare during the 4th quarter worth about $840,286,000. Finally, Northern Trust Corp increased its position in shares of HCA Healthcare by 12.4% during the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock worth $605,694,000 after purchasing an additional 223,248 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Down 2.1%

NYSE HCA traded down $7.22 during trading on Friday, reaching $334.26. 3,175,863 shares of the stock traded hands, compared to its average volume of 1,334,458. The firm has a market cap of $80.41 billion, a price-to-earnings ratio of 14.05, a price-to-earnings-growth ratio of 1.17 and a beta of 1.47. The stock's 50-day moving average price is $373.81 and its 200 day moving average price is $345.92. The company has a quick ratio of 1.06, a current ratio of 1.19 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.07% and a return on equity of 1,063.91%. The firm had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the previous year, the company earned $5.50 earnings per share. The business's revenue for the quarter was up 6.4% on a year-over-year basis. Analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. HCA Healthcare's payout ratio is currently 12.81%.

Insider Activity

In other news, COO Jon M. Foster sold 15,698 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer directly owned 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on HCA shares. Robert W. Baird reiterated a "neutral" rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Morgan Stanley set a $410.00 target price on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research report on Monday, June 9th. Royal Bank Of Canada restated an "outperform" rating and issued a $404.00 price objective (up previously from $376.00) on shares of HCA Healthcare in a research report on Monday, June 23rd. Truist Financial raised their price objective on shares of HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Finally, Bank of America cut shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective for the company. in a research report on Wednesday, July 16th. Eight analysts have rated the stock with a hold rating, nine have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $399.46.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.